Locally advanced gastric cancer

MEET THE EXPERTS ALL PROGRAMMES DEVELOPED COLLABORATIONS CONTACT

Locally advanced gastric cancer

Dr Samuel J Klempner, Prof. Sebastian Stintzing

Dr Sebastian Stintzing and Dr Samuel Klempner provide an update on the diagnosis and treatment of locally advanced gastric cancer

Dr Samuel J Klempner

GI Medical Oncologist

Massachusetts General Hospital

United States (US)

Prof. Sebastian Stintzing

GI Medical Oncologist

Charité Universitaetsmedizin

Germany

Biography Disclosures

Dr Samuel J Klempner

GI Medical Oncologist

Massachusetts General Hospital

United States (US)

Dr Samuel J. Klempner is a GI medical oncologist with research and clinical focus on esophagogastric cancers and cancer genomics. Dr Klempner completed his residency in internal medicine at Brigham and Women’s Hospital/Harvard Medical School, followed by a combined hematology-oncology fellowship at Beth Israel Deaconess Medical Center/Harvard Medical School. While at Harvard, Dr Klempner studied the mechanisms of resistance to targeted therapies in tumor cells in the lab of Dr Lewis Cantley, PhD. Dr Klempner is board certified in medical oncology, hematology, and internal medicine. Prior to joining The Angeles Clinic and Research Institute Dr Klempner served as an Assistant Clinical Professor in the division of Hematology-Oncology at the University of California Irvine. Dr Klempner’s research interests include the intersection of genomics and immunotherapies, oncogene-driven tumors, acquired resistance, and experimental therapeutics. Dr Klempner is involved in professional societies including the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), and the European Society for Medical Oncology (ESMO).

Dr Samuel J Klempner has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Astellas, AstraZeneca, BMS, Coherus, Daiichi-Sankyo, Eli Lilly, Merck, Novartis, Nuvalent Therapuetics and Sanofi.

Biography Disclosures

Prof. Sebastian Stintzing

GI Medical Oncologist

Charité Universitaetsmedizin

Germany

Sebastian Stintzing (M.D.), Professor of Medicine, is Head of the Division of Oncology and Haematology, Department of Medicine (CCM), Charité Universitaetsmedizin Berlin. His research focuses on predictive and prognostic biomarkers in the treatment of GI cancer with a special focus on colorectal cancer. From 2012 to 2014, he was a research fellow at the Sharon Carpenter Laboratory at the University of Southern California Norris Comprehensive Cancer Center, Los Angeles, U.S.A. He coordinated the translational part and assisted the clinical study conduct of several studies and earned his Postdoctoral Lecture Qualification with a thesis on prognostic and predictive factors in the treatment of metastatic colorectal cancer. In 2012, he received the prestigious Research Fellowship Award from the German Cancer Aid in Germany and started work at the University of Southern California. Dr Stintzing is member of national and international cancer associations and speaker of the steering committee of the working group Colorectal Carcinoma of the German AIO.

Prof. Sebastian Stintzing has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AMGEN, Bayer, BMS, Isofol, Lilly, Merck KGaA, MSD, Pierre Fabre, Roche, Sanofi, Taiho, Takeda

time | open 5 min | Sep 2021

This programme was made for you: your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

download resources

Download the slides

This programme was made for you: your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.

Other programmes of interest

Prof. Dimitrios Tsakiris

Dr Lars Asmis

Podcast

2 min

Cancer and Thrombosis

Sep 2023

Dr Elisa Agostinetto

Prof. Valentina Guarneri

Interactive patient case

15 min

Oral SERDs: New Endocrine Therapy Options in ER+ Advanced or Meta...

Sep 2023

Prof. Chee-Kiat Tan

Publication

5 min

Surveillance and Diagnosis of HCC in Asia: Poster Presentation at...

Sep 2023

Assoc. Prof. Gerald Prager

Video

4 min

Long-term Response in Advanced Colorectal Cancer

Sep 2023

Prof. Dr Jeroen Dekervel

Dr Amit Singal

Podcast

29 min

A New Era in Treating Patients with Advanced HCC

Sep 2023

Dr Jaume Capdevila

Asst. Prof. Mauro Cives

Micro learning

30 min

Accreditation: EACCME

Recognising, Diagnosing and Managing Neuroendocrine Tumours

Aug 2023

Acromegaly and Neuroendocrine Tumours Global Survey

Publication

15 min

Acromegaly and Neuroendocrine Tumours Global Survey

Aug 2023

Prof. Shaheenah Dawood

Assoc. Clinical Professor Rena Callahan

Podcast

74 min

Oral SERDs in ER+ Breast Cancer

Aug 2023

Dr Tracy L Stockley

Prof. David Hong

Podcast

24 min

An Introduction to Molecular Testing

Jul 2023

Dr Neal Shore

Dr Andrew J. Armstrong

Video

10 min

Clinical Implementation of Testing and PARPi as Monotherapy or in...

Aug 2023

Janet Forgenie

Video

3 min

Nursing Support for mCRPC Patients During Radiopharmaceutical Tre...

Jul 2023

Prof. Andrea Sartore-Bianchi

Video

5 min

Conference Update: ASCO and WCGIC 2023

Jul 2023

Other programmes developed by Dr Samuel J Klempner

Dr Samuel J Klempner

GI Medical Oncologist

Massachusetts General Hospital

United States (US)

Dr Samuel J Klempner

Dr Elizabeth Smyth

Podcast

86 min

Gastroesophageal Cancer: Clinical Case Discussions

Jul 2023

Dr Yelena Janjigian

Dr Elizabeth Smyth

Dr Samuel J Klempner

Video

73 min

Current and Future Gastroesophageal Cancer Treatments

Apr 2023

Prof. Jenny Seligmann

Dr Dominik Modest

Dr Thomas Winder

And others...

47 min

GI CONNECT Update from ESMO 2022

Sep 2022

Dr Samuel J Klempner

Assoc. Prof. Autumn McRee

Prof. Shubham Pant

And others...

E-learning

5 min

GI CONNECT CRC Masterclass: accredited elearning, slides and summ...

2019

Dr Samuel J Klempner

5 min

GI CONNECT Update from ASCO GI 2020: cancers of the upper GI trac...

Jan 2020

Other programmes developed by Prof. Sebastian Stintzing

Prof. Sebastian Stintzing

GI Medical Oncologist

Charité Universitaetsmedizin

Germany

Prof. Sebastian Stintzing

Dr Juan Manuel O'Connor

9 min

Optimising treatment sequencing for mCRC, third line and beyond

Jan 2023

Review paper on intermittent vs continuous treatment in the maintenance treatment setting of metastatic colorectal cancer

Prof. Tanios Bekaii-Saab

Assoc. Prof. Yu Sunakawa

Prof. Sebastian Stintzing

0 min

Review paper on intermittent vs continuous treatment in the maint...

2016

Prof. Sebastian Stintzing

5 min

GI CONNECT Update from ASCO GI 2015: upper GI cancer

2015

Prof. Sebastian Stintzing

5 min

Colorectal cancer with microsatellite instability and immunothera...

2015

Prof. Sebastian Stintzing

5 min

What is the relevance of molecular subtypes in GI tumors?

2018

Prof. Shubham Pant

Dr Thomas Winder

Prof. Sebastian Stintzing

5 min

What are the pros and cons of adjuvant treatment in stage II colo...

Sep 2021

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.